Hemopurifier Filters Ebola, Hep C, Metastatic Melanoma: Interview with James A. Joyce, CEO of Aethlon Medical
Ins and Outs August 5th, 2009 Editors News Facebook Twitter Google+ LinkedIn U.S. Psyche Bedevils Health Effort … [WSJ] Which Health Players Are Spending the Most On Lobbying? [WSJ] FDA Approves Livalo (pitavastatin), a New Cholesterol-Lowering Drug… [FDA] From gorilla to human: a new immunodeficiency virus found… [Nature] Americans Spend $34 Billion a Year on ‘Alternative’ Medicine… [WSJ] No, Pharma’s Digital Future Isn’t All Social Media… [AdAge] Feds: Jackson Memorial patients’ records were sold in scheme… [Miami Herald] Sun Exposure May Trigger Certain Autoimmune Diseases in Women… [NIH] Cooling therapy for cardiac arrest survivors is as cost-effective as accepted treatments… [American Heart Association] Barriers to telehealth services are being removed; even by Medicare… [HealthBlog@MSFT] Medtronic and Abbott Laboratories Resolve Global Vascular Patent Disputes… [Medtronic] Kamada’s Biologics License Application for IV-AAT to Treat Alpha-1 Antitrypsin Deficiency is Accepted for Review by the US Food and Drug Administration… [Kamada] Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery… [Cardiorobotics ] NASA Studies Cellulose for Food and Biofuel Production… [NASA] Is There Long-Term Brain Damage After Bypass Surgery? More Evidence Puts the Blame on Heart Disease Itself… [Johns Hopkins] Rare Childhood Blood Disorder Sidesteps Immune System’s Attack… [HHMI] In Miami, Cuban Docs Fill Primary Care Void… [WSJ]
Your information will never be shared with any third party.